Fig. 2From: Outcomes of patients with active cancers and pre-existing cardiovascular diseases infected with SARS-CoV-2A and B Major Adverse Cardiac Events (MACE) over time by study cohort (A) and cancer type (B) during the early COVID-19 periodBack to article page